Physician profile
Michael Lersten
NPI 1942602743
$5,683.76
in general payments reported to CMS, 2019-2025
11 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,682 · 2020: $356 · 2021: $192 · 2022: $1,475 · 2023: $594 · 2024: $1,254 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,072 · Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,072.01 |
| Food and Beverage | $906.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,033.99 | 2019-2024 | Senza |
| Pacira Pharmaceuticals Incorporated | $1,290.14 | 2022-2024 | Iovera |
| Mml US, INC. | $1,176.03 | 2022 | |
| Spr Therapeutics, INC | $325.09 | 2023-2025 | Sprint Pns System |
| Medtronic, INC. | $227.59 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Curonix LLC | $180.54 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $174.00 | 2020 | |
| Vertos Medical, INC. | $124.43 | 2022-2023 | Mild Device Kit |
| Stryker Corporation | $108.46 | 2020-2025 | Spinejack, Optablate, Mild Device Kit |
| Saluda Medical Americas, INC. | $22.49 | 2025 | Evoke |
| Bioventus LLC | $21.00 | 2025 | Xcell |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lersten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.